1. New oral anticoagulants—what the cardiothoracic surgeon needs to know
Tsuyoshi Kaneko, MD, Maroun Yammine, MD, Sary F. Aranki, MD 
The Journal of Thoracic and Cardiovascular Surgery 
Volume 148, Issue 5, Pages e1 (November 2014)
DOI: /j.jtcvs
Copyright © 2014 The American Association for Thoracic Surgery Terms and Conditions

2. Figure 1
Perioperative management of a patient undergoing major cardiothoracic surgery who is taking (A) warfarin or (B) new oral anticoagulants (NOACs). UFH, Unfractionated heparin; LMWH, low-molecular-weight heparin; INR, international normalized ratio; aPTT, activated partial thromboplastin time; FFP, fresh frozen plasma; DVT, deep venous thrombosis; CrCl, creatinine clearance; TT, thrombin time. *Risk stratification according to American College of Chest Physician 2012 guidelines.27
The Journal of Thoracic and Cardiovascular Surgery  , e1DOI: ( /j.jtcvs )
Copyright © 2014 The American Association for Thoracic Surgery Terms and Conditions